LA JOLLA PHARMACEUTICAL CO (LJPC)

US5034596040 - Common Stock

6.22  0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2022-6-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
46.49M75.72M33.42M23.05M10.06M
Cost Of Goods
8.87M13.49M7.82M2.39M1.64M
Gross Profit
37.62M62.23M25.60M20.66M8.41M
Operating Expenses
40.19M40.40M61.44M130.47M202.47M
Research and Development
2.52M5.01M23.01M85.33M117.30M
Selling, General, and Administrative Expenses
37.67M35.39M38.43M45.13M85.16M
Operating Income
-2.57M21.83M-35.84M-109.80M-194.05M
Interest Income/Expense
-9.95M-10.45M-9.82M-8.65M-5.42M
Other Income/Expense
14.21M8.33M6.23M1.94MN/A
Income Before Taxes
4.02M19.71M-39.42M-116.51M-199.47M
Income Tax
49.00K49.00KN/AN/A0.00
Net Income
3.97M19.66M-39.42M-116.51M-199.47M
EBITDA
-916.00K23.49M-33.00M-105.25M-189.64M
 
Per Share Data
EPS Diluted Total Ops
0.110.58-1.44-4.30-7.85
Non GAAP EPS
-0.030.57-1.45-4.30-7.90
 
Statistics
Gross Profit Margin
80.92%82.19%76.60%89.63%83.60%
Profit Margin
8.54%25.96%-117.95%-505.47%-1982.80%
Operating Profit Margin
-5.53%28.83%-107.24%-476.36%-1928.93%

All data in USD

Charts